Last update 26 May 2025

Tasadenoturev

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
Adenovirus-5 delta 24 RGD, IE-CRAd, AD-DELTA24-RGD
+ [10]
Action
modulators, inhibitors, stimulants
Mechanism
Bcl-2 modulators(Apoptosis regulator Bcl-2 modulators), TIM3 inhibitors(Hepatitis A virus cellular receptor 2 inhibitors), Cell death stimulants
Originator Organization
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States), Rare Pediatric Disease (United States), PRIME (European Union), Fast Track (European Union)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GliosarcomaPhase 2
United States
06 Oct 2016
GliosarcomaPhase 2
Canada
06 Oct 2016
Recurrent GlioblastomaPhase 2
United States
06 Oct 2016
Recurrent GlioblastomaPhase 2
Canada
06 Oct 2016
Brain Stem GliomaPhase 1
Spain
26 May 2017
Brain Stem GliomaPhase 1
Spain
26 May 2017
Diffuse Intrinsic Pontine GliomaPhase 1
Spain
26 May 2017
Diffuse Intrinsic Pontine GliomaPhase 1
Spain
26 May 2017
EpendymomaPhase 1
United States
01 Feb 2009
Glioblastoma MultiformePhase 1
United States
01 Feb 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
ieckisbryr(cffvspcrez) = uqopwcdvog xsqerqzsrf (hyhnvqkbbi )
Positive
20 Nov 2020
Lomustine+Temozolomide
-
Phase 1
27
bxtjquguum(rwuxeanjtf) = The most frequent grade 3-4 AEs across treatment groups were fatigue pldjlnmqqu (kykvywcjpl )
Positive
30 May 2017
Not Applicable
-
Delta24RGD oncolytic adenovirus
tmceppzoeq(wmljugvdzq) = Dose limiting toxicities with respect to patient safety were not encountered ospjtxheld (whyuqopeww )
-
23 Oct 2014
Phase 1
-
aolcosgmvp(mdtqvwrjgf) = predominant CD8+ lymphocytic infiltration daayjfiuig (unqzjqbsmb )
-
15 Apr 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free